Adaptive Biotechnologies (ADPT) Amortizatization of Intangibles (2018 - 2026)
Adaptive Biotechnologies' (ADPT) quarterly Amortizatization of Intangibles came in at $419000.0 in Q1 2026, down 56.26% year-on-year from $958000.0 in Q1 2025, and up 45.49% quarter-over-quarter from $288000.0 in Q4 2025.
Adaptive Biotechnologies (ADPT) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies has disclosed Amortizatization of Intangibles across 9 years of filings, most recently posting $419000.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $419000.0, down 56.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (down 30.38% YoY), and the FY2025 annual result was $2.5 million, up 47.5% from the prior year.
- Amortizatization of Intangibles came in at $419000.0 for Q1 2026 at Adaptive Biotechnologies, up from $288000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.1 million in Q4 2022 to a low of -$4.5 million in Q4 2023.
- The 5-year median for Amortizatization of Intangibles is $423000.0 (2022), against an average of $119764.7.
- Peak annual rise in Amortizatization of Intangibles reached 148.61% in 2023, while the deepest fall reached 517.53% in 2023.
- Adaptive Biotechnologies' Amortizatization of Intangibles stood at $1.1 million in 2022, then slumped by 517.53% to -$4.5 million in 2023, then surged by 109.46% to $428000.0 in 2024, then plunged by 32.71% to $288000.0 in 2025, then jumped by 45.49% to $419000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $419000.0 (Q1 2026), $288000.0 (Q4 2025), and $428000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 171.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 430.00 Mn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 434.00 Mn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | - |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 7.10 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 18.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | - |
| 10 | Adaptive Biotechnologies | 2.66 Bn | 2.45 Bn | 52.17 Mn | 419,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 419,000.00 |
| Mar 31, 2026 | 419,000.00 |
| Dec 31, 2025 | 288,000.00 |
| Dec 31, 2025 | 288,000.00 |
| Sep 30, 2025 | 428,000.00 |
| Sep 30, 2025 | 428,000.00 |
| Jun 30, 2025 | 423,000.00 |
| Jun 30, 2025 | 423,000.00 |
| Mar 31, 2025 | 958,000.00 |
| Mar 31, 2025 | 958,000.00 |
| Dec 31, 2024 | 428,000.00 |
| Dec 31, 2024 | 428,000.00 |
| Sep 30, 2024 | 428,000.00 |
| Sep 30, 2024 | 428,000.00 |
| Jun 30, 2024 | 424,000.00 |
| Jun 30, 2024 | 424,000.00 |
| Mar 31, 2024 | 423,000.00 |
| Mar 31, 2024 | 423,000.00 |
| Dec 31, 2023 | -4.53 Mn |
| Dec 31, 2023 | -4.53 Mn |